Cell culture media can be a significant source of variability in biopharmaceutical manufacturing, but identifying and understanding the source of media variability can be complex.
©iStock, Murat Photo
In biopharmaceutical development and manufacturing, cell culture media variability can affect cellular growth, viability, productivity, and the quality profile of therapeutic proteins.1 However, identifying and understanding the source of media variability can be complex. Differences may originate from incoming raw materials or emerge during preparation and use. Furthermore, as bioprocesses become increasingly data-driven and manufacturing timelines continue to tighten, there is a growing need for culture media analysis approaches that can provide broad compositional insight quickly to help identify variability before it propagates through manufacturing processes.
The Complexity Behind Media Variability
Cell culture media can be a significant source of variability in biopharmaceutical manufacturing, with differences arising between raw material lots and as media undergo preparation and processing. Quality control for cell culture media may involve monitoring lot-to-lot variability and performing raw material screening to detect impurities, contaminants, counterfeit materials, and formulation inconsistencies that could compromise quality, regulatory compliance, and patient safety.
During use, preparation and processing parameters such as temperature, mixing power, and processing time can alter media composition.2 Storage conditions and sterilization or treatment steps may similarly affect sensitive components. For manufacturers, the challenge is distinguishing acceptable media composition variation from changes that could affect process performance or product quality.
Analysis Strategies and Bottlenecks
Conventional cell culture media analytical measurements such as pH and osmolality provide useful process information but cannot comprehensively characterize composition. High-performance liquid chromatography and liquid chromatography-mass spectrometry can provide detailed molecular information, but these approaches may require sample preparation, separations, and longer analysis times.1,2
This creates a practical gap between the need for broad compositional insight and the speed required for modern bioprocess development and manufacturing. Traditional assays can provide highly specific measurements of individual components, but analyzing a complex medium comprehensively may require multiple techniques and considerable time.
Broad analytical approaches that can rapidly compare media fingerprints therefore offer an opportunity to identify atypical lots, monitor changes during processing, and investigate unexpected shifts in culture performance. Spectroscopic approaches have demonstrated the potential to detect media variability and its root causes during preparation, supporting more proactive process monitoring and troubleshooting.
A Molecular Fingerprint for Faster Decisions
The Veloci BioPharma Analyzer from HORIBA Scientific uses A-TEEM™ (Absorbance-Transmittance Excitation Emission Matrix) spectroscopy to generate molecular fingerprints of complex samples. The approach combines fluorescence information with absorbance and transmission measurements, providing selectivity without conventional chromatographic separations.
The Veloci BioPharma Analyzer from HORIBA Scientific uses A-TEEM™ spectroscopy to generate molecular fingerprints of complex cell culture media samples.
Horiba Scientific
For cell culture media quality analysis, A-TEEM fingerprints help scientists evaluate lot-to-lot variability and track fluorescent components including aromatic amino acids and vitamins. This can give biopharmaceutical industry experts a rapid way to compare incoming materials, investigate unexpected differences, and monitor media quality alongside established analytical methods. The instrument can also provide rapid molecular fingerprints that help monitor changes during storage and characterize media during bioprocessing.
This technology supports earlier detection of variability and more informed investigations when product or process performance changes. By bringing rapid, information-rich spectroscopy closer to routine testing, the Veloci BioPharma Analyzer can help address the tension between comprehensive characterization and the turnaround times demanded by modern manufacturing.
- McGillicuddy N, et al. Examining the sources of variability in cell culture media used for biopharmaceutical production. Biotechnol Lett. 2018;40(1):5-21.
- Brunner M, et al. Towards robust cell culture processes - Unraveling the impact of media preparation by spectroscopic online monitoring. Eng Life Sci. 2019;19(10):666-680.
